Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,542 | 25,286 | 2,225 | 4,272 | 11,834 |
| Marketable Securities | 6,034 | 15,979 | N/A | N/A | N/A |
| Receivables | 355 | 585 | 2,551 | 183 | 363 |
| Other current assets | 2,357 | 3,243 | 1,106 | 7,558 | 2,694 |
| TOTAL | $29,288 | $45,093 | $5,882 | $12,013 | $14,891 |
| Non-Current Assets | |||||
| PPE Net | 14,979 | 17,058 | 15,142 | 16,357 | 17,572 |
| Other Non-Current Assets | 4,768 | 6,867 | 6,048 | 3,773 | 4,387 |
| TOTAL | $19,747 | $23,925 | $21,190 | $20,130 | $21,959 |
| Total Assets | $49,035 | $69,018 | $27,072 | $32,143 | $36,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,000 | 11,000 | 10,000 | 4,000 | 4,000 |
| Accounts payable and accrued liabilities | 2,912 | 5,054 | 2,235 | 2,425 | 2,694 |
| Accrued Expenses | 400 | 2,292 | 5,319 | 808 | 795 |
| Other current liabilities | 3,262 | 3,999 | 877 | 5,217 | 6,607 |
| TOTAL | $25,162 | $31,889 | $26,610 | $15,164 | $18,072 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,600 | 4,000 | 4,000 | 4,000 | 4,000 |
| Deferred Revenues | 5,388 | 4,657 | 4,363 | 1,204 | 2,115 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 125 |
| TOTAL | $8,613 | $6,548 | $5,026 | $5,289 | $5,719 |
| Total Liabilities | $33,775 | $38,437 | $31,636 | $20,453 | $23,791 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,831 | 62,999 | 62,981 | 23,036 | 22,994 |
| Common Shares | 64 | 63 | 8 | 23 | 23 |
| Retained earnings | -183,262 | -166,955 | -153,372 | -136,862 | -135,418 |
| Other shareholders' equity | 9 | -79 | -6 | -18 | 0 |
| TOTAL | $15,260 | $30,581 | $-4,564 | $11,690 | $13,059 |
| Total Liabilities And Equity | $49,035 | $69,018 | $27,072 | $32,143 | $36,850 |